tartrazine has been researched along with Experimental Mammary Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Awounfack, FC; Kada, MM; Kalgonbe, AY; Mindang, ELN; Ndinteh, DT; Njamen, D; Zingue, S | 1 |
1 other study(ies) available for tartrazine and Experimental Mammary Neoplasms
Article | Year |
---|---|
Oral administration of tartrazine (E102) accelerates the incidence and the development of 7,12-dimethylbenz(a) anthracene (DMBA)-induced breast cancer in rats.
Topics: 9,10-Dimethyl-1,2-benzanthracene; alpha-Fetoproteins; Animals; Biomarkers, Tumor; Carcinogens; Carcinoma; Estradiol; Female; Mammary Neoplasms, Experimental; Mucin-1; Organ Size; Oxidative Stress; Rats; Rats, Wistar; Tartrazine; Tumor Burden | 2021 |